Personal tools

Coexpression cluster:C3961: Difference between revisions

From FANTOM5_SSTAR

Jump to: navigation, search
No edit summary
No edit summary
Line 3: Line 3:
|gostat_on_coexpression_clusters=GO:0007052!mitotic spindle organization and biogenesis!0.0115094783939715!3925$GO:0007051!spindle organization and biogenesis!0.0115094783939715!3925$GO:0007019!microtubule depolymerization!0.0115094783939715!3925$GO:0031109!microtubule polymerization or depolymerization!0.0120098904980572!3925$GO:0051261!protein depolymerization!0.0138113740727658!3925$GO:0015631!tubulin binding!0.0167638054868715!3925$GO:0000226!microtubule cytoskeleton organization and biogenesis!0.0218751576928899!3925$GO:0005874!microtubule!0.0489403037795832!3925$GO:0007017!microtubule-based process!0.0489403037795832!3925$GO:0000278!mitotic cell cycle!0.0489403037795832!3925
|gostat_on_coexpression_clusters=GO:0007052!mitotic spindle organization and biogenesis!0.0115094783939715!3925$GO:0007051!spindle organization and biogenesis!0.0115094783939715!3925$GO:0007019!microtubule depolymerization!0.0115094783939715!3925$GO:0031109!microtubule polymerization or depolymerization!0.0120098904980572!3925$GO:0051261!protein depolymerization!0.0138113740727658!3925$GO:0015631!tubulin binding!0.0167638054868715!3925$GO:0000226!microtubule cytoskeleton organization and biogenesis!0.0218751576928899!3925$GO:0005874!microtubule!0.0489403037795832!3925$GO:0007017!microtubule-based process!0.0489403037795832!3925$GO:0000278!mitotic cell cycle!0.0489403037795832!3925
|id=C3961
|id=C3961
|ontology_enrichment_celltype=
|ontology_enrichment_disease=DOID:162!5.36e-22!235;DOID:14566!1.08e-21!239;DOID:0050686!7.22e-14!137;DOID:2531!1.84e-13!51;DOID:0060083!1.84e-13!51;DOID:1240!6.54e-12!39;DOID:8692!4.02e-09!31;DOID:0050687!6.04e-08!143
|ontology_enrichment_uberon=UBERON:0001017!3.16e-18!82;UBERON:0000073!1.49e-17!94;UBERON:0001016!1.49e-17!94;UBERON:0005743!5.58e-17!86;UBERON:0001049!2.78e-14!57;UBERON:0005068!2.78e-14!57;UBERON:0006241!2.78e-14!57;UBERON:0007135!2.78e-14!57;UBERON:0000955!4.55e-14!69;UBERON:0006238!4.55e-14!69;UBERON:0002020!3.52e-12!34;UBERON:0003528!3.52e-12!34;UBERON:0002780!5.21e-12!41;UBERON:0001890!5.21e-12!41;UBERON:0006240!5.21e-12!41;UBERON:0002616!7.09e-12!59;UBERON:0002346!1.89e-11!90;UBERON:0003080!2.11e-11!42;UBERON:0000924!3.39e-11!173;UBERON:0006601!3.39e-11!173;UBERON:0001893!3.56e-11!34;UBERON:0002791!5.00e-11!33;UBERON:0001869!7.81e-11!32;UBERON:0000956!8.77e-11!25;UBERON:0000203!8.77e-11!25;UBERON:0003075!2.04e-10!86;UBERON:0007284!2.04e-10!86;UBERON:0004121!2.65e-10!169;UBERON:0002619!7.17e-10!22;UBERON:0000153!1.60e-09!129;UBERON:0007811!1.60e-09!129;UBERON:0001950!5.09e-09!20;UBERON:0000033!6.18e-09!123;UBERON:0003056!8.04e-09!61
}}
}}

Revision as of 14:42, 21 May 2012


Full id: C3961_duodenum_occipital_Neurons_merkel_mesenchymal_temporal_parietal



Phase1 CAGE Peaks

Hg19::chr1:26228136..26228182,-p1@BC040585
Hg19::chr1:26230247..26230298,-p4@STMN1
Hg19::chr1:26231214..26231239,-p3@STMN1


Enriched pathways on this co-expression cluster<b>Summary:</b><br>Canonical pathway gene sets were compiled from Reactome, Wikipathways and KEGG. For the major signaling pathways, the transcriptionally-regulated genes (downstream targets) were obtained from Netpath. Combined, the canonical pathways and downstream targets totaled 489 human gene sets. The corresponding M. musculus gene sets were inferred by homology using the HomoloGene database. Enrichment for each of the canonical 489 pathways and gene sets included in the co-expression cluster was assessed by the hypergeometric probability. The resulting P values were also then adjusted by the Benjamini-Hochberg method for multiple comparisons.<br><b>Analyst: </b>Emmanuel Dimont<br><br>link to source dataset<br>data


No results for this coexpression

Enriched Gene Ontology terms on this co-expression cluster<b>Summary:</b> Results for GOStat analysis on co-expressed clusters. Each cluster with promoters mapping to at least two different genes was analysed with GOStat (PMID: 14962934) with default parameter. <br><b>Analyst:</b> Erik Arner<br><br>link to source dataset<br>data


GO IDGO nameFDR corrected p-value
GO:0007052mitotic spindle organization and biogenesis0.0115094783939715
GO:0007051spindle organization and biogenesis0.0115094783939715
GO:0007019microtubule depolymerization0.0115094783939715
GO:0031109microtubule polymerization or depolymerization0.0120098904980572
GO:0051261protein depolymerization0.0138113740727658
GO:0015631tubulin binding0.0167638054868715
GO:0000226microtubule cytoskeleton organization and biogenesis0.0218751576928899
GO:0005874microtubule0.0489403037795832
GO:0007017microtubule-based process0.0489403037795832
GO:0000278mitotic cell cycle0.0489403037795832



Enriched sample ontology terms on this co-expression cluster<b>Summary:</b>To summarize promoter activities (expression profile of a TSS region) across ~1000 samples, we performed enrichment analysis based on FANTOM5 Sample Ontology (FF ontology). The question here is “in which type of samples the promoter is more active”. To answer this question, we compared expressions (TPMs) in the samples associated with a sample ontology term and the rest of the samples by using the Mann-Whitney rank sum test. To summarize ontologies enriched in this co-expression cluster, we ran the same analysis on an averaged expression profile of all promoters that make up. <b>Analyst:</b> Hideya Kawaji <br><br>links to source dataset<br><br><br>uberon_data<br>disease_data<br>


Uber Anatomy
Ontology termp-valuen
central nervous system3.16e-1882
regional part of nervous system1.49e-1794
nervous system1.49e-1794
neural tube2.78e-1457
neural rod2.78e-1457
future spinal cord2.78e-1457
neural keel2.78e-1457
brain4.55e-1469
future brain4.55e-1469
gray matter3.52e-1234
brain grey matter3.52e-1234
regional part of forebrain5.21e-1241
forebrain5.21e-1241
future forebrain5.21e-1241
regional part of brain7.09e-1259
neurectoderm1.89e-1190
anterior neural tube2.11e-1142
ectoderm3.39e-11173
presumptive ectoderm3.39e-11173
telencephalon3.56e-1134
regional part of telencephalon5.00e-1133
cerebral hemisphere7.81e-1132
cerebral cortex8.77e-1125
pallium8.77e-1125
neural plate2.04e-1086
presumptive neural plate2.04e-1086
ectoderm-derived structure2.65e-10169
regional part of cerebral cortex7.17e-1022
anterior region of body1.60e-09129
craniocervical region1.60e-09129
neocortex5.09e-0920
head6.18e-09123
pre-chordal neural plate8.04e-0961
Disease
Ontology termp-valuen
cancer5.36e-22235
disease of cellular proliferation1.08e-21239
organ system cancer7.22e-14137
hematologic cancer1.84e-1351
immune system cancer1.84e-1351
leukemia6.54e-1239
myeloid leukemia4.02e-0931
cell type cancer6.04e-08143


Overrepresented TFBS (DNA) motifs on this co-expression cluster<b>Summary:</b>The values shown are the p-values for overrepresentation of the motif in this coexpression cluster. So a small p-value means a strong overrepresentation. <b>Analyst:</b> Michiel de Hoon <br><br>link to source data <br> Novel motifs <br>data <br><br> Jaspar motifs <br>data


Novel motifs



JASPAR motifs

Motifs-log10(p-value)

{{{tfbs_overrepresentation_jaspar}}}



ENCODE TF ChIP-seq peak enrichment analysis<b>Summary:</b> For each TF and each co-expression cluster, the number of promoters with ENCODE TF ChIP signal was compared with the rest of promoters from the robust set using Fisher's exact test. Clusters with significant ChIP enrichment (q <= 0.05) after Benjamini-Hochberg correction were retained. <br><b>Analyst:</b> Erik Arner<br><br>link to source dataset<br><br>data


No analysis results for this cluster

Relative expression of the co-expression cluster<b>Summary:</b>Co-expression clusters are compared against FANTOM5 samples to obtain relative expression. <br><b>Analyst:</b>NA<br><br>link to data source<br> data


This analysis result is provided for C0 - C305 clusters.